1. Home
  2. TMDX vs SHOO Comparison

TMDX vs SHOO Comparison

Compare TMDX & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SHOO
  • Stock Information
  • Founded
  • TMDX 1998
  • SHOO 1990
  • Country
  • TMDX United States
  • SHOO United States
  • Employees
  • TMDX N/A
  • SHOO N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SHOO Shoe Manufacturing
  • Sector
  • TMDX Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • TMDX 2.3B
  • SHOO 1.9B
  • IPO Year
  • TMDX 2019
  • SHOO 1993
  • Fundamental
  • Price
  • TMDX $123.56
  • SHOO $23.11
  • Analyst Decision
  • TMDX Buy
  • SHOO Hold
  • Analyst Count
  • TMDX 10
  • SHOO 6
  • Target Price
  • TMDX $127.33
  • SHOO $26.00
  • AVG Volume (30 Days)
  • TMDX 830.9K
  • SHOO 1.3M
  • Earning Date
  • TMDX 07-30-2025
  • SHOO 07-30-2025
  • Dividend Yield
  • TMDX N/A
  • SHOO 3.63%
  • EPS Growth
  • TMDX N/A
  • SHOO N/A
  • EPS
  • TMDX 1.41
  • SHOO 2.32
  • Revenue
  • TMDX $488,227,000.00
  • SHOO $2,284,080,000.00
  • Revenue This Year
  • TMDX $34.07
  • SHOO $12.44
  • Revenue Next Year
  • TMDX $20.76
  • SHOO $8.22
  • P/E Ratio
  • TMDX $87.63
  • SHOO $9.96
  • Revenue Growth
  • TMDX 64.43
  • SHOO 10.34
  • 52 Week Low
  • TMDX $55.00
  • SHOO $19.05
  • 52 Week High
  • TMDX $177.37
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 45.61
  • SHOO 42.95
  • Support Level
  • TMDX $139.31
  • SHOO $22.78
  • Resistance Level
  • TMDX $145.50
  • SHOO $24.24
  • Average True Range (ATR)
  • TMDX 5.88
  • SHOO 0.85
  • MACD
  • TMDX -2.71
  • SHOO -0.28
  • Stochastic Oscillator
  • TMDX 12.94
  • SHOO 8.71

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: